AI

Can Global Partnerships Future-Proof Epidemic Preparedness? SK bioscience, Merck (MSD), and Hilleman Unite to Strengthen Ebola Vaccine Supply

23 January 2026 Executive Summary A global vaccine partnership has been established between SK bioscience, MSD (Merck &…

ByByAnuja Singh Jan 24, 2026

Is Strategic Out-Licensing the Fastest Path to Global Scale? Restari Secures $230 Million PDE-5 Deal with AriBio

23 January 2026 Executive Summary Restari has secured exclusive global out-licensing rights from AriBio for a next-generation PDE-5…

ByByAnuja Singh Jan 24, 2026

Is AI Poised to Replace the Traditional Drug Discovery Lab? Nvidia CEO Signals a Paradigm Shift in Pharma R&D

23 January 2026 Executive Summary Nvidia CEO Jensen Huang has underscored the transformative potential of artificial intelligence in…

ByByAnuja Singh Jan 24, 2026

Is Short-Term Cost Control Undermining Long-Term Innovation? Novartis Calls for Structural Reform in Global Healthcare

23 January 2026 Executive Summary Novartis has issued a call for structural reform in global healthcare policy, warning…

ByByAnuja Singh Jan 23, 2026
Image Not Found

Roche Signals Dual Growth Strategy: Price Reform Alignment in the U.S. and Aggressive Expansion Across Oncology and Obesity

January 2026 | Pharma & Policy | Bloomberg Interview Insight Roche is positioning itself for its next growth…

ByByAnuja Singh Jan 26, 2026

Can Amgen’s Strategic Partnerships Redefine Access and Growth in the GLP‑1 Market?

23 January 2026 Executive Summary Amgen is actively exploring strategic collaborations with telehealth platforms and other access-focused partners…

ByByAnuja Singh Jan 24, 2026
Scroll to Top